Patents
Patents for A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
09/2003
09/25/2003WO2003003818A3 Dried citrus peel use in commercial poultry litter
09/25/2003WO2002098339A3 Zinc containing compositions for anti-viral use
09/25/2003WO2002076410A3 Cosmetic and dermatological preparations comprising a content of a hop extract or hop-malt extract
09/25/2003WO2002000240A3 Compositions and methods for treating females sexual response
09/25/2003US20030181665 Which lack N-glycosidase-rRNA activity; kits
09/25/2003US20030181515 Administering to a subject in need of pain relief a medicinal ointment comprising an active kavalactone selected from the group consisting of dihydrokawain, dihydromethysticin, kawain and medicinally acceptable carrier
09/25/2003US20030181429 Topically applying betulinic acid or a betulinic acid derivative to tumor site
09/25/2003US20030181397 Synergistic composition of bioactive fraction isolated barleria prionitis linn and a method of treatment for hepatotoxicity, immuno-deficiency and fatigue and a process thereof
09/25/2003US20030181394 Carbobydrates such as alpha-D-galactopyranosyl-1,2-glycerol and/or isomers, obtained by solvent extraction from algae, for use as viricides or anticarcinogenic agents
09/25/2003US20030180406 Treatment of diseases involving defective gap junctional communication
09/25/2003US20030180405 For cosmstics, drugs; antiinflamamtory agents; oxidation resistance
09/25/2003US20030180404 Methods of treating clinical diseases with isoflavones
09/25/2003US20030180403 Process for the preparation of hydroxylated lecithin from crude soybean lecithin
09/25/2003US20030180402 Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from Acacia
09/25/2003US20030180400 Non-fiber extract of psyllium with anti-tumorigenic effects and method for identifying the same
09/25/2003US20030180399 Therapeutic/edible compositions comprising herbal ingredients and methods for treating hyperglycemia
09/25/2003US20030180398 Composition for treating gastric ulcer and a process for preparing the same
09/25/2003US20030180397 Prevent degradation of sensitive material
09/25/2003US20030180395 Anxiolytic agents; analgesics; sleep disorders; antiinflammatory agents; central nervous system disorders
09/25/2003US20030180394 Extracts from sophora species, method for producing the same and their use
09/25/2003US20030180393 Cleaning digestion tracks
09/25/2003US20030180349 Administering before or after onset of disease
09/25/2003US20030180339 Topical treatment of skin
09/25/2003US20030180318 Composition having anticancer activity
09/25/2003US20030180308 Deglycosylated ricin toxin a-chain vaccine
09/25/2003US20030180231 Cosmetics, skin disorders; sunscreen agents; aging resistance
09/25/2003CA2479350A1 Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
09/24/2003EP1346726A1 Sympathetic-activating perfume composition
09/24/2003EP1345632A2 Absorbent articles with non-aqueous compositions containing botanicals
09/24/2003EP1345624A1 Induction of tolerance
09/24/2003EP1345616A2 Reducing cellular damage in the human body
09/24/2003EP1345615A1 Use of tinospora extract in the treatment of immune system-modulated disorders
09/24/2003EP1345614A1 IMPROVED AND STABLE EXTRACT FROM i HYPERICUM PERFORATUM L. /i , METHOD FOR THE PRODUCTION THEREOF AND ITS USE AS A TOPICAL MEDICAMENT
09/24/2003EP1345501A1 Nutritional and therapeutical preparations having antioxidant activity
09/24/2003CN1444659A Koji molds and use thereof for preparing cholesterol-lowering products
09/24/2003CN1444475A Preparation with vascular protective and anti-oxidative effect and use thereof
09/24/2003CN1444474A Nonoral preparation having three-layer structure
09/24/2003CN1444446A Fungicidal composition comprising high dehydrated vegetable oil
09/23/2003US6624192 Diacetylrhein containing aloe-emodin components is subjected to a liquid-liquid partitioning between a polar organic solvent which is only partly miscible with water and an aqueous phase of pH 6.5 to 7.5 and the diacetylrhein is
09/23/2003US6624148 Synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biomolecules from the activated mast cells, composed of
09/23/2003US6623775 Applying hop extract to a food product or beverage to inhibit growth of Clostridium botulinum
09/23/2003US6623769 Administration of lycopene for combating skin/mucous membrane damage
09/23/2003US6623768 Extracted with supercritical fluid carbon dioxide
09/23/2003US6623767 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative
09/23/2003US6623766 Process for insecticidal formulation effective in controlling malarial vector, mosquitoes
09/23/2003US6623745 Emollient
09/23/2003US6623743 Supplementing food with antriocyanins, bioflavonoids and 1-(3',4'-dihydroxycinnamoyl) -2,3- or 2,5- dihydroxycyclo-pentane
09/23/2003US6623728 Cosmetic skin care compositions and containing gum mastic
09/23/2003US6623725 Cosmetic compact or creme powder
09/23/2003CA2100295C A psyllium-hydrocolloid gum composition
09/18/2003WO2003075943A2 Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising wogonin, isoliquiritigenin and/or coumestrol
09/18/2003WO2003075942A1 Vitamin and zinc monomethionine compositions
09/18/2003WO2003075941A1 Methods for the treatment and prevention of overweight in mammals
09/18/2003WO2003075940A1 An extract of lentinus lepideus and composition comprising the same showing immune enhancing activity
09/18/2003WO2003075938A1 Coumarins extractions and their uses for treating hypertension disease
09/18/2003WO2003075937A1 Chinese preparation for treating enteritis ulcer colitis and preparation method thereof
09/18/2003WO2003075891A1 Dispersed solid-containing complex carbohydrate
09/18/2003WO2003075861A1 Antioxidative preparations
09/18/2003WO2003075812A1 Controlled delivery patch of active ingredient
09/18/2003WO2003075685A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
09/18/2003WO2003075679A1 Additive for livestock feed
09/18/2003WO2003035007A3 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
09/18/2003WO2003028600B1 Wipe formulation
09/18/2003WO2002102388A3 Active ingredient combination of e.g. galanthamine or deoxypeganine and e.g. acamprosate or memantine for treating an addiction such as alcoholism
09/18/2003US20030176653 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
09/18/2003US20030176493 Having antineoplastic activity; antioxidant activity; and inhibit DNA topoisomerase II enzyme
09/18/2003US20030176467 Nicotine compositions
09/18/2003US20030176393 Product of heat treatment of uronic acid, food, drink or drug including the product
09/18/2003US20030175374 Oxidation resistance; anticancer agents, antiinflammatory agents; sunscreen agents
09/18/2003US20030175373 Osteoporosis therapy; plant extract
09/18/2003US20030175372 Resveratol; plant extracts
09/18/2003US20030175371 Antimicrobial agents isolated from Aloe vera
09/18/2003US20030175370 Dry mixture of carbohydrates and drugs; wound healing agents
09/18/2003US20030175369 Natural moths repellent compositions
09/18/2003US20030175368 Using plant extract for in situ decomposition of fats
09/18/2003US20030175366 Plant Extracts and Methods of Treating Skin Therewith
09/18/2003US20030175365 Natural drug induced differentiation cancer cells to resemble normal cells
09/18/2003US20030175363 Pharmaceutical composition and process for isolation of trans-tetracos-15-enoic acid and method of treatment for hepatotoxicity
09/18/2003US20030175361 Using selenium in combination with drugs used conventionally to treat psychiatric or neurological disorders
09/18/2003US20030175333 Invisible patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients onto the skin
09/18/2003US20030175328 Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
09/18/2003US20030175283 Synergystic mixtures of mint oils, terpenes and ajuvants used as bactericides
09/18/2003US20030175258 Mixing shoots of Pinaceae plants with water and saccharides followed by spontaneous fermenting with yeasts to form remedies for allergic diseases; side effect reduction; for treatment of asthma, atopic dermatitis
09/18/2003US20030175244 Capsid-modified recombinant adenovirus and methods of use
09/18/2003US20030175234 Green tea based polyphenols, including catechins, such as epigallocatechin gallate, epigallocatechin, epicathechin 3-gallate and epicatechin; antioxidant properties, to assist in minimizing free radical induced skin damage
09/18/2003CA2478684A1 Dispersed solid-containing complex carbohydrate
09/18/2003CA2478663A1 Methods for the treatment and prevention of overweight in mammals
09/18/2003CA2477329A1 Controlled delivery patch of active ingredient
09/17/2003EP1344528A1 External skin preparations and process for producing the same
09/17/2003EP1344516A1 Antioxidative composition
09/17/2003EP1343893A1 Production of stilbenes in transgenic plants and the method of producing thereof
09/17/2003EP1343860A1 A process for preparing vegetable oil fractions rich in non-tocolic, high-melting, unsaponifiable matter
09/17/2003EP1343826A1 Polysaccharide compound having immune stimulating activity
09/17/2003EP1343513A1 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use
09/17/2003EP1343512A1 Injectable solution with anti-inflammatory effect and process for manufacturing the same
09/17/2003EP1343486A1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration
09/17/2003EP1343472A2 Thixotropic nasal spray
09/17/2003EP1343390A2 Materials and methods for the treatment or prevention of obesity
09/17/2003EP1169056B1 Caspase-8 inhibitors for immunosuppression.
09/17/2003EP0914114B1 Methods of treating type i hypersensitivity using monophosphoryl lipid a